Lean Changeover guidance

newsJul 30, 2018 | Phorum : Drug Substance | News

These two related papers help those involved with the design and organization of product changeover drug substance operations to justify the elimination of elastomer change-outs and reduce other changeovers. Using a science-based risk management approach the guides show how to ensure that value-added work is the sole focus of changeovers and how unnecessary changeover activity can be eliminated, reduced or removed from the facility down time.

 

 

 

Follow BioPhorum

Related tags

Recent releases

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Share This